Interferons and dry eye in sjögren’s syndrome

Yoko Ogawa, Eisuke Shimizu, Kazuo Tsubota

Research output: Contribution to journalReview articlepeer-review

40 Citations (Scopus)


Various cytokines, including interferon (IFN)-γ and IL-17, are augmented, and autoreactive T cells and B cells are activated in the immune pathogenesis of Sjögren’s syndrome (SS). In particular, IFNs are involved in both the early stages of innate immunity by high level of type I IFN in glandular tissue and sera and the later stages of disease progression by type I and type II IFN producing T cells and B cells through B cell activating factor in SS. Genetically modified mouse models for some of these molecules have been reported and will be discussed in this review. New findings from human SS and animal models of SS have elucidated some of the mechanisms underlying SS-related dry eye. We will discuss IFN-γ and several other molecules that represent candidate targets for treating inflammation in SS-related dry eye.

Original languageEnglish
Article number3548
JournalInternational journal of molecular sciences
Issue number11
Publication statusPublished - 2018 Nov 10


  • Animal model
  • Dry eye
  • Interferon-γ
  • Sjögren’s syndrome

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Interferons and dry eye in sjögren’s syndrome'. Together they form a unique fingerprint.

Cite this